Medicines Evaluation Unit Limited (03779957)

Company details

Type: Private Limited Company
Incorporated: 1999-05-28
Country of origin: United Kingdom

Accounts & filings

Accounts last filed: 2025-03-31 · MEDIUM
Next accounts due: 2026-09-30 in 104 days
Confirmation statement: last made up 2025-05-28 · next due 2026-06-117 days overdue

View full filing history at Companies House →

Registered office

3 Forbury Place
23 Forbury Road
Reading
United Kingdom
Rg1 3jh

Peer comparison

Compared against 1,843 UK companies across all sectors (not enough peers in 72190 to compare) within the Large bracket (£10M–£100M net assets).

Net assets Above typical

P25medianP75

This company: —
Turnover Above typical

P25medianP75

This company: —
Profit / loss Typical

P25medianP75

This company: —

See where this company ranks

Included with the £1 AI analysis unlock — one payment unlocks both for this company. Yours forever.

Based on this company's latest filed accounts (to Mar 2025) · Full accounts — profit & loss and balance sheet.

Unlock for £1

Compares this company to 1,843 UK peers in Large bracket, by net assets, turnover, profitability, and more.

Financial health

Derived from the filed accounts to Mar 2025. Figures only — not advice.

See this company's financial health

£1 unlocks the liquidity & profitability ratios, risk signals, the AI analysis and peer comparison for this company. One payment, yours forever.

Based on this company's latest filed accounts (to Mar 2025) · Full accounts — profit & loss and balance sheet.

Unlock for £1

Ratios and signals derived from this company's filed Companies House figures only.

Accounts

Based on this company's latest filed accounts (to Mar 2025) · Full accounts — profit & loss and balance sheet.

Year ending	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Profit & loss
Turnover	£18,188,618 →0.0%	£18,166,529 ↑3.4%	£17,573,750 ↑2.5%	£17,147,512 ↑16.6%	£14,709,377
Gross profit	£10,210,721 ↓4.2%	£10,656,907 ↑12.3%	£9,487,039 ↑3.9%	£9,135,251 ↑31.0%	£6,972,400
Operating profit	£5,623,626 ↓8.6%	£6,154,022 ↑20.3%	£5,114,795 ↓1.3%	£5,183,656 ↑25.1%	£4,144,067
Profit before tax	£6,032,655 ↓14.9%	£7,086,083 ↑42.4%	£4,976,762 ↓9.9%	£5,524,703 ↑15.0%	£4,802,186
Profit / loss	£5,339,721 ↓27.5%	£7,360,585 ↑43.0%	£5,145,652 ↓9.3%	£5,673,816 ↑12.7%	£5,035,645
Balance sheet
Fixed assets	£3,123,606 ↓71.2%	£10,846,286 ↑5.9%	£10,241,092 ↓2.1%	£10,463,063 ↑24.8%	£8,381,114
Current assets	£37,806,548 ↑44.3%	£26,192,542 ↑9.9%	£23,842,949 ↑26.0%	£18,919,861 ↑23.4%	£15,336,430
Cash	£33,216,149 ↑70.3%	£19,504,181 ↑17.3%	£16,627,503 ↑31.8%	£12,612,851 ↑6.2%	£11,879,257
Debtors	£4,590,399 ↓31.4%	£6,688,361 ↓7.3%	£7,215,446 ↑14.4%	£6,307,010 ↑82.4%	£3,457,173
Net current assets	£35,221,510 ↑47.8%	£23,838,585 ↑18.9%	£20,056,308 ↑26.4%	£15,861,942 ↑15.2%	£13,768,707
Net assets	£38,296,895 ↑10.6%	£34,636,650 ↑14.6%	£30,226,961 ↑15.0%	£26,283,526 ↑19.0%	£22,086,762
Equity	£38,296,895 ↑10.6%	£34,636,650 ↑14.6%	£30,226,961 ↑15.0%	£26,283,526 ↑19.0%	£22,086,762
Other
Average employees	160 ↑7.4%	149 ↓8.0%	162 ↑15.7%	140 ↑14.8%	122
Dividends paid	£1,062,912 ↓64.0%	£2,950,896 ↑103.3%	£1,451,697 ↓1.7%	£1,477,160 ↑5.2%	£1,404,401

Source: filed iXBRL accounts at Companies House. P&L items are only published by medium and large companies; small companies file abridged or micro-entity accounts where the P&L is not public.

Industry (SIC codes)

72190 · Other research and experimental development on natural sciences and engineering

Officers (20)

Jtc (Uk) Limited · Corporate Secretary appointed 2025-06-27
Morton-Morys, Andrea · Director appointed 2025-06-13
Randall, Kerry Louise · Director appointed 2025-06-13
Turland, Kevin John · Director appointed 2025-06-13
Batty, Elizabeth Pamela · Director appointed 2024-01-23 resigned 2025-06-13
Vestbo, Jorgen, Professor · Director appointed 2018-12-19 resigned 2025-06-13
Mcnish, Andrew Edward · Director appointed 2015-11-16 resigned 2025-06-13
Woodcock, Ashley Arthur, Professor · Director appointed 2015-11-16 resigned 2025-06-13
Singh, Sukh Dave, Professor · Director appointed 2004-12-20 resigned 2025-06-13
Rogers, David · Director appointed 2003-09-08 resigned 2025-06-13
Barber, Philip Vernon, Dr · Director appointed 2000-11-20 resigned 2025-06-13
Niven, Robert Mclay, Dr · Director appointed 2005-01-01 resigned 2024-01-23
Webb, Anthony Kevin · Director appointed 2000-11-20 resigned 2018-09-01
Pickering, Charles Anthony Cary, Professor · Director appointed 1999-05-28 resigned 2018-09-01
Langley, Stephen, Dr · Director appointed 2003-09-08 resigned 2005-02-14
Fielding, Benjamin James · Secretary appointed 2000-03-01 resigned 2001-05-21
Bilyard, Kevin George · Director appointed 2000-03-01 resigned 2001-03-30
Williams, Andrew James, Dr · Director appointed 1999-05-28 resigned 2001-01-19
Deansgate Company Formations Limited · Corporate Nominee Director appointed 1999-05-28 resigned 1999-05-28
Britannia Company Formations Limited · Corporate Nominee Secretary appointed 1999-05-28 resigned 1999-05-28

People with significant control (2)

North West Lung Research Centre Charity Ceased 2025-06-13

Corporate Entity Psc · notified 2016-04-06

Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors
Iqvia Ltd. Active

Corporate Entity Psc · notified 2025-06-13

Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors

Mortgages & charges (2)

All charges satisfied.

A registered charge Satisfied 037799570002

Held by Clydesdale Bank PLC (Trading as Both Clydesdale and Yorkshire Bank) (Company Number SC001111)

Created 2021-05-20 · satisfied 2025-03-22
Debenture Satisfied

Held by North West Lung Centre

Created 2006-04-18 · satisfied 2021-04-28

Fixed and floating charges over the undertaking and all property and assets present and future including goodwill bookdebts buildings fixtures fixed plant and machinery. See the mortgage charge document for full details.

Recent filings (15)

2026-06-17 Director details changed CH01 Officers
2026-06-10 Confirmation statement (with updates) CS01 Confirmation statement
2026-03-31 Medium-company accounts AA Accounts
2025-11-25 Resolution (paper) RESOLUTIONS Resolution
2025-11-20 Capital name of class of shares (paper) SH08 Capital
2025-11-19 Change registered office address company with date old address new address AD01 Address
2025-10-28 Memorandum and articles (paper) MA Incorporation
2025-10-28 Resolution (paper) RESOLUTIONS Resolution
2025-10-24 Change account reference date company current shortened AA01 Accounts
2025-09-03 Cessation of a person with significant control PSC07 PSC
2025-09-03 Notification of a person with significant control PSC02 PSC
2025-07-03 Appoint corporate secretary company with name date AP04 Officers
2025-06-20 Appointment of director AP01 Officers
2025-06-20 Appointment of director AP01 Officers
2025-06-19 Termination director company with name termination date TM01 Officers

Showing the 15 most recent filings. View full filing history at Companies House.